UB Paderborn / Katalog / Suche / in CDI

MP-15.20 Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients with Disseminated Nonseminomatous Testicular Tumors: Is a Post-Chemotherapy Retroperitoneal Lymphadenectomy Needed After Complete Remission?

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S145-S145

2011

Volltextzugriff (PDF)

UP-03.112 Redo-Retroperitoneal Lymphadenectomy (RPLA) for Nonseminomatous Germ Cell Testicular Tumors (NSGCT): Clinical Presentation, Patterns of Recurrence and Outcome

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S380-S380

2011

Volltextzugriff (PDF)

MP-05.10: The Long Term Side Effects of Adjuvant Radiotherpy (RTX) vs Carboplatin (CBDCA) Chemotherapy (CT) in Clinical Stage A (CS-A) Seminomatous Testicular Tumours (STT)

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S65-S65

2009

Volltextzugriff (PDF)

MP-05.09: Salvage Retroperitoneal Lymphadenectomy (RPLA) in Chemorefractory Nonseminomatous Testicular Germ Cell Tumours (NSGCTT)

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S65-S65

2009

Volltextzugriff (PDF)

UP-3.060: Impact of Finasteride on Perioperative Bleeding before Transurethral Vapor Resection of the Prostate

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S312-S312

2009

Volltextzugriff (PDF)

UP-3.070: The Prospective Study of the Efficacy of Tamsulosin, Serenoa Repens, and Serenoa Repens Plus Tamsulosin Treatment for Patients with Benign Prostatic Hyperplasia: CombTSR Study

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S315-S316

2009

Volltextzugriff (PDF)

4537 POSTER Late recurrences (LR) in germ cell testicular tumours (GCTT): a population-based experience over 23 years

European journal of cancer supplements, 2007, Vol.5 (4), p.309-310

Argirovic, D

2007

Volltextzugriff (PDF)

S4 POPULATION-BASED STUDY OF PERIOPERATIVE MORTALITY AFTER RETROPERITONEAL LYMPHADENECTOMY FOR NONSEMINOMATOUS TESTICULAR TUMORS

European urology supplements : official journal of the European Association of Urology, 2012-10, Vol.11 (4), p.133-134

2012

Volltextzugriff (PDF)

S5 RECURRENCES IN NONSEMINOMATOUS TESTICULAR TUMORS WITH NO VIABLE CANCER AT POSTCHEMOTHERAPY RETROPERITONEAL LYMPHADNECTOMY

European urology supplements : official journal of the European Association of Urology, 2012-10, Vol.11 (4), p.134-134

2012

Volltextzugriff (PDF)

Public awareness of testicular cancer symptomatology and the value of testicular self-examination

European urology supplements : official journal of the European Association of Urology, 2015-10, Vol.14 (6), p.e1230-e1230

2015

Volltextzugriff (PDF)

MP-11.19

Urology (Ridgewood, N.J.), 2006-11, Vol.68, p.127

Argirovic, D.

2006

Volltextzugriff (PDF)

S212: Silodosin (SIL) in the management of patients (pts) in Acute Urinry Retention (AUR) from Benign Prostatic Hyperplasia (BPH)

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (7), p.e1543-e1543

2014

Volltextzugriff (PDF)

S258: Long-term follow-up of cisplatin combination Chemotherapy (C) in patients (pts) with disseminated Nonseminomatous Testicular Tumors (NSTT): Is a Post-Chemotherapy Retroperitoneal Lymphadenectomy (PC-RPLA) needed after Complete Remission (CR)?

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (7), p.e1574-e1574

2014

Volltextzugriff (PDF)

MP-11.19: Bilateral germ cell testicular tumors: a report of 44 patients with long term follow-up

Urology (Ridgewood, N.J.), 2006, Vol.68, p.127-127

Argirovic, D.

2006

Volltextzugriff (PDF)

1090 Influence of diet quality on lower urinary tract symptoms

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e1090-e1090

2014

Volltextzugriff (PDF)

S273 Trends in the incidence of germ cell testicular tumors (GCTTs) between 1976 and 2005

European urology supplements : official journal of the European Association of Urology, 2013-10, Vol.12 (4), p.e1381, S273-e1381, S273

2013

Volltextzugriff (PDF)

729 RECURRENCES IN NONSEMINOMATOUS TESTICULAR TUMOURS WITH NO VIABLE CANCER AT POSTCHEMOTHERAPY RETROPERITONEAL LYMPHADNECTOMY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.237-237

2010

Volltextzugriff (PDF)

N20 PREDICTING RECURRENCE FOLLOWING POSTCHEMOTHERAPY (PC) RETROPERITONEAL LYMPHADENECTOMY (RPLA) FOR RESIDUAL FIBROSIS OR TERATOMA

European urology supplements : official journal of the European Association of Urology, 2010, Vol.9 (6), p.540-540

2010

Volltextzugriff (PDF)

518 Impact of medical therapy on transurethral resection of the prostate (TURP): Two decades of change

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e518-e518

2013

Volltextzugriff (PDF)

S210: Influence of diet quality on lower urinary tract symptoms

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (7), p.e1541-e1541

2014

Volltextzugriff (PDF)

S257: Public awareness of testicular cancer symptomatology and the value of testicular self-examination

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (7), p.e1573-e1573

2014

Volltextzugriff (PDF)

C1 THE CHANGING PRESENTATION OF GERM CELL TESTICULAR TUMORS (GCTTS) BETWEEN 1976 AND 2005

European urology supplements : official journal of the European Association of Urology, 2012-10, Vol.11 (4), p.83-83

2012

Volltextzugriff (PDF)

S140 IMPACT OF MEDICAL THERAPY ON TRANSURETHRAL RESECTION OF THE PROSTATE (TURP): TWO DECADES OF CHANGE

European urology supplements : official journal of the European Association of Urology, 2012-10, Vol.11 (4), p.167-167

2012

Volltextzugriff (PDF)

S3 LONG-TERM OUTCOME AFTER POSTCHEMOTHERAPY RETROPERITONEAL LYMPHADNECTOMY IN PTS WITH RESIDUAL TERATOMA

European urology supplements : official journal of the European Association of Urology, 2012-10, Vol.11 (4), p.133-133

2012

Volltextzugriff (PDF)

C2 CLINICAL OUTCOME FOLLOWING POST-CHEMOTHERAPY RETROPERITONEAL LYMPHADENECTOMY IN PATIENTS WITH INTERMEDIATE – AND POOR-RISK NONSEMINOMATOUS TESTICULAR TUMORS

European urology supplements : official journal of the European Association of Urology, 2012-10, Vol.11 (4), p.83-83

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

MP-15.20 Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients with Disseminated Nonseminomatous Testicular Tumors: Is a Post-Chemotherapy Retroperitoneal Lymphadenectomy Needed After Complete Remission?

UP-03.112 Redo-Retroperitoneal Lymphadenectomy (RPLA) for Nonseminomatous Germ Cell Testicular Tumors (NSGCT): Clinical Presentation, Patterns of Recurrence and Outcome

MP-05.10: The Long Term Side Effects of Adjuvant Radiotherpy (RTX) vs Carboplatin (CBDCA) Chemotherapy (CT) in Clinical Stage A (CS-A) Seminomatous Testicular Tumours (STT)

MP-05.09: Salvage Retroperitoneal Lymphadenectomy (RPLA) in Chemorefractory Nonseminomatous Testicular Germ Cell Tumours (NSGCTT)

UP-3.060: Impact of Finasteride on Perioperative Bleeding before Transurethral Vapor Resection of the Prostate

UP-3.070: The Prospective Study of the Efficacy of Tamsulosin, Serenoa Repens, and Serenoa Repens Plus Tamsulosin Treatment for Patients with Benign Prostatic Hyperplasia: CombTSR Study

4537 POSTER Late recurrences (LR) in germ cell testicular tumours (GCTT): a population-based experience over 23 years

S4 POPULATION-BASED STUDY OF PERIOPERATIVE MORTALITY AFTER RETROPERITONEAL LYMPHADENECTOMY FOR NONSEMINOMATOUS TESTICULAR TUMORS

S5 RECURRENCES IN NONSEMINOMATOUS TESTICULAR TUMORS WITH NO VIABLE CANCER AT POSTCHEMOTHERAPY RETROPERITONEAL LYMPHADNECTOMY

Public awareness of testicular cancer symptomatology and the value of testicular self-examination

MP-11.19

S212: Silodosin (SIL) in the management of patients (pts) in Acute Urinry Retention (AUR) from Benign Prostatic Hyperplasia (BPH)

S258: Long-term follow-up of cisplatin combination Chemotherapy (C) in patients (pts) with disseminated Nonseminomatous Testicular Tumors (NSTT): Is a Post-Chemotherapy Retroperitoneal Lymphadenectomy (PC-RPLA) needed after Complete Remission (CR)?

MP-11.19: Bilateral germ cell testicular tumors: a report of 44 patients with long term follow-up

1090 Influence of diet quality on lower urinary tract symptoms

S273 Trends in the incidence of germ cell testicular tumors (GCTTs) between 1976 and 2005

729 RECURRENCES IN NONSEMINOMATOUS TESTICULAR TUMOURS WITH NO VIABLE CANCER AT POSTCHEMOTHERAPY RETROPERITONEAL LYMPHADNECTOMY

N20 PREDICTING RECURRENCE FOLLOWING POSTCHEMOTHERAPY (PC) RETROPERITONEAL LYMPHADENECTOMY (RPLA) FOR RESIDUAL FIBROSIS OR TERATOMA

518 Impact of medical therapy on transurethral resection of the prostate (TURP): Two decades of change

S210: Influence of diet quality on lower urinary tract symptoms

S257: Public awareness of testicular cancer symptomatology and the value of testicular self-examination

C1 THE CHANGING PRESENTATION OF GERM CELL TESTICULAR TUMORS (GCTTS) BETWEEN 1976 AND 2005

S140 IMPACT OF MEDICAL THERAPY ON TRANSURETHRAL RESECTION OF THE PROSTATE (TURP): TWO DECADES OF CHANGE

S3 LONG-TERM OUTCOME AFTER POSTCHEMOTHERAPY RETROPERITONEAL LYMPHADNECTOMY IN PTS WITH RESIDUAL TERATOMA

C2 CLINICAL OUTCOME FOLLOWING POST-CHEMOTHERAPY RETROPERITONEAL LYMPHADENECTOMY IN PATIENTS WITH INTERMEDIATE – AND POOR-RISK NONSEMINOMATOUS TESTICULAR TUMORS

Suchergebnisse filtern